Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency

[Image: see text] The innate immune receptor nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) represents an important target for the development of structurally defined small molecule immunomodulatory compounds that have great potential to be used either as vaccine adjuvants or...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzelj, Samo, Bizjak, Špela, Jakopin, Žiga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377006/
https://www.ncbi.nlm.nih.gov/pubmed/35978688
http://dx.doi.org/10.1021/acsmedchemlett.2c00121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377006/
https://www.ncbi.nlm.nih.gov/pubmed/35978688
http://dx.doi.org/10.1021/acsmedchemlett.2c00121

Ejemplares similares